tiprankstipranks
Trending News
More News >
Leafly Holdings (LFLH)
OTHER OTC:LFLH
US Market

Leafly Holdings (LFLH) AI Stock Analysis

Compare
141 Followers

Top Page

LFLH

Leafly Holdings

(OTC:LFLH)

Select Model
Select Model
Select Model
Rating:43Neutral
Price Target:
$36.00
▼(-2.70% Downside)
LFLYD's overall score of 43 reflects significant financial challenges as the primary drag, with ongoing losses, declining revenue, and negative equity signaling profitability and solvency risks. Technical indicators further weigh on the score with a clear downtrend and bearish momentum. Valuation offers no meaningful upside due to negative earnings, contributing to a cautious outlook.

Leafly Holdings (LFLH) vs. SPDR S&P 500 ETF (SPY)

Leafly Holdings Business Overview & Revenue Model

Company DescriptionLeafly Holdings, Inc. owns and operates a platform to provide consumers with cannabis information and connects consumers to cannabis brands and licensed retailers. It offers subscription-based marketplace listings, digital advertising solutions, and software as a service-based tools to cannabis retailers and brands; and information, reviews, menus, and ordering and delivery options to its audience through its website and mobile applications. The company was founded in 2010 and is headquartered in Seattle, Washington.
How the Company Makes MoneyLeafly generates revenue through multiple streams, primarily from digital advertising, subscription services, and partnerships with cannabis retailers. The company's advertising revenue comes from brands paying to promote their products on the Leafly platform, leveraging its extensive user base and engagement metrics. Additionally, Leafly offers subscription-based services to dispensaries and cannabis businesses, providing them with tools for inventory management, online ordering, and customer engagement. Partnerships with industry players, such as cannabis producers and distributors, further enhance its revenue model by allowing Leafly to provide targeted marketing and analytics services, thus strengthening its market position and driving earnings.

Leafly Holdings Financial Statement Overview

Summary
Income Statement
25
Negative
Balance Sheet
15
Very Negative
Cash Flow
35
Negative
Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Leafly Holdings Technical Analysis

Technical Analysis Sentiment
Last Price37.00
Price Trends
50DMA
100DMA
200DMA
Market Momentum
MACD
RSI
STOCH
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LFLH, the sentiment is undefined. The current price of 37 is equal to the 20-day moving average (MA) of ―, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a undefined sentiment for LFLH.

Leafly Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
60
Neutral
$48.67B4.58-11.27%4.14%2.83%-41.78%
53
Neutral
$34.17M-0.49-83.28%15.35%
52
Neutral
$21.62M-0.17-59.91%
51
Neutral
$9.29M-3.6295.23%34.97%
49
Neutral
$155.96M-18.9430.71%73.43%
43
Neutral
$232.18K-0.04-16.42%39.35%
* Communication Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
LFLH
Leafly Holdings
37.00
-162.95
-81.50%
LDWY
Lendway
5.25
1.03
24.41%
RNTX
Rein Therapeutics
1.30
-0.62
-32.29%
LFMD
LifeMD
3.24
-2.47
-43.26%
BAOS
Baosheng Media Group Holdings
3.36
-0.08
-2.33%
NEUP
Neuphoria Therapeutics
4.02
-1.08
-21.18%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 23, 2025